CTOs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

Viking Group Inc.

For over 100 years the name Viking has represented global leadership in fire protection. We lead the industry in quality and innovation because fire protection is all we do, and our single focus is to support and enhance the efforts of independent fire sprinkler contractors. We believe that protecting people and property from fire transcends the bottom line, and we never stop asking "what do our customers need to be successful?" Today, The Viking Group provides independent fire sprinkler contractors with integrated solutions for any fire protection challenge. Rely on Viking to deliver: Unmatched Quality: Our reputation has been earned by focusing on continuous improvement in all elements of our business – from the products we manufacture to the services we provide. Product Breadth: The largest selection of fixed fire protection products and services ensures single-point solutions for any fire protection challenge. Experienced Support: Knowledgeable customer service and technical support at every point in the project process. Innovation that Matters: From valves that are easier to install and maintain, to automated fabrication capabilities, Viking innovates to solve problems and strengthen your business. Everywhere You Need Us: With our global network of independent distribution partners and dozens of locations, Vikings products and services are available when and where you need them.

SAENZ-GARCIA LAW, PLLC

We provide tailored, compassionate, and professional immigration legal services to individuals and families. We are a dedicated ally on the journey to a brighter future, we go beyond immigration law.

BASF

BASF is a global chemical company founded in 1865 in Mannheim, Germany. Initially focused on dyes and inorganic chemicals, it has grown to become the worlds leading chemical enterprise, operating across six continents. The company emphasizes innovation, sustainability, and customer-centric solutions. BASFs diverse portfolio includes chemicals, materials, industrial solutions, surface technologies, nutrition, and agricultural solutions. It offers products such as synthetic dyes, fertilizers, polymers, crop protection products, and ingredients for the food and personal care industries. With a strong presence in various sectors like automotive, construction, and agriculture, BASF serves a wide range of customers globally. The company is committed to corporate responsibility, integrating environmental and social considerations into its operations. Its research and development efforts focus on resource efficiency, renewable energy, and principles of the circular economy. BASFs rebranding in 2015 reflects its dedication to creating sustainable solutions.

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.